Litigation Details for INCYTE CORP. v. APOTEX INC. (D.N.J. 2024)
✉ Email this page to a colleague
INCYTE CORP. v. APOTEX INC. (D.N.J. 2024)
| Docket | ⤷ Sign Up | Date Filed | 2024-03-28 |
| Court | District Court, D. New Jersey | Date Terminated | |
| Cause | Assigned To | Christine P. O'Hearn | |
| Jury Demand | Referred To | Matthew J. Skahill | |
| Patents | 7,598,257; 8,415,362; 8,722,693; 8,822,481; 8,829,013 | ||
| Link to Docket | External link to docket | ||
Details for INCYTE CORP. v. APOTEX INC. (D.N.J. 2024)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2024-03-28 | 1 | Complaint | United States Patent Nos. 7,598,257 (the “’257 patent”); 8,415,362 (the “’362 patent”); 8,722,693 (… (the “’693 patent”); 8,822,481 (the “’481 patent”); and 8,829,013 (the “’013 patent”) (collectively… 1. This is an action for patent infringement under the patent laws of the United States, 35 …collectively, the “patents-in-suit”). The patents-in-suit are owned by Incyte Corporation and/or Incyte Holdings… The Patents-in-Suit 5. On October 6, 2009, the United States Patent and Trademark | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
